Identification of variants in genes associated with hypertrophic cardiomyopathy in Mexican patients

被引:1
|
作者
Garcia-Vielma, Catalina [1 ]
Lazalde-Cordova, Luis Gerardo [1 ]
Arzola-Hernandez, Jose Cruz [2 ]
Gonzalez-Aceves, Erick Noel [2 ]
Lopez-Zertuche, Herminio [3 ]
Guzman-Delgado, Nancy Elena [2 ]
Gonzalez-Salazar, Francisco [1 ]
机构
[1] Inst Mexicano Seguro Social, Ctr Invest Biomed Noreste, Dept Citogenet, Monterrey, Mexico
[2] Inst Mexicano Seguro Social, Dr Alfonso J Trevino Trevino Ctr Med Nacl Noreste, Dept Electrofisiol, Unidad Med Alta Especial,Hosp Cardiol, Monterrey, Mexico
[3] Inst Mexicano Seguro Social, Hosp Gen Zona 4, Monterrey, Mexico
关键词
Hypertrophic cardiomyopathy; Sudden death; MYH7; MYBPC3; Gene variants; CARDIAC-ARRHYTHMIAS; MUTATION SPECTRUM; AMERICAN-COLLEGE; PREVALENCE; PHENOTYPE; TROPONIN; BINDING; COHORT; HETEROGENEITY; POPULATION;
D O I
10.1007/s00438-023-02048-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The objective of this work was to identify genetic variants in Mexican patients diagnosed with hypertrophic cardiomyopathy (HCM). According to world literature, the genes mainly involved are MHY7 and MYBPC3, although variants have been found in more than 50 genes related to heart disease and sudden death, and to our knowledge there are no studies in the Mexican population. These variants are reported and classified in the ClinVar (PubMed) database and only some of them are recognized in the Online Mendelian Information in Men (OMIM). The present study included 37 patients, with 14 sporadic cases and 6 familial cases, with a total of 21 index cases. Next-generation sequencing was performed on a predesigned panel of 168 genes associated with heart disease and sudden death. The sequencing analysis revealed twelve (57%) pathogenic or probably pathogenic variants, 9 of them were familial cases, managing to identify pathogenic variants in relatives without symptoms of the disease. At the molecular level, nine of the 12 variants (75%) were single nucleotide changes, 2 (17%) deletions, and 1 (8%) splice site alteration. The genes involved were MYH7 (25%), MYBPC3 (25%) and ACADVL, KCNE1, TNNI3, TPM1, SLC22A5, TNNT2 (8%). In conclusion; we found five variants that were not previously reported in public databases. It is important to follow up on the reclassification of variants, especially those of uncertain significance in patients with symptoms of the condition. All patients included in the study and their relatives received family genetic counseling.
引用
收藏
页码:1289 / 1299
页数:11
相关论文
共 50 条
  • [1] Identification of variants in genes associated with hypertrophic cardiomyopathy in Mexican patients
    Catalina García-Vielma
    Luis Gerardo Lazalde-Córdova
    José Cruz Arzola-Hernández
    Erick Noel González-Aceves
    Herminio López-Zertuche
    Nancy Elena Guzmán-Delgado
    Francisco González-Salazar
    Molecular Genetics and Genomics, 2023, 298 : 1289 - 1299
  • [2] Malignant effects of multiple rare variants in sarcomere genes on the prognosis of patients with hypertrophic cardiomyopathy
    Wang, Jizheng
    Wang, Yilu
    Zou, Yubao
    Sun, Kai
    Wang, Zhimin
    Ding, Hu
    Yuan, Jinqing
    Wei, Wei
    Hou, Qing
    Wang, Hu
    Liu, Xuan
    Zhang, Hongju
    Ji, Yun
    Zhou, Xianliang
    Sharma, Ravi K.
    Wang, Daowen
    Ahmad, Ferhaan
    Hui, Rutai
    Song, Lei
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 (09) : 950 - 957
  • [3] Determining pathogenicity of genetic variants in hypertrophic cardiomyopathy: importance of periodic reassessment
    Das, Jipin K.
    Ingles, Jodie
    Bagnall, Richard D.
    Semsarian, Christopher
    GENETICS IN MEDICINE, 2014, 16 (04) : 286 - 293
  • [4] Pathogenic genes and clinical prognosis in hypertrophic cardiomyopathy
    Hong, Ying
    Xi, Hu-Tao
    Yang, Xin-Yi
    Su, Wilber W.
    Li, Xiao-Ping
    WORLD JOURNAL OF CARDIOLOGY, 2025, 17 (01):
  • [5] Incidentally Identified Variants in Genes Associated With Hypertrophic Cardiomyopathy Are Rarely Associated With Pathologic Ventricular Hypertrophy
    Jones, Edward G.
    Tunuguntla, Hari
    Rosenfeld, Jill A.
    Yang, Yaping
    Allen, Hugh D.
    Penny, Daniel J.
    Kim, Jeffrey J.
    Landstrom, Andrew P.
    CIRCULATION, 2017, 136
  • [6] Identification of Underlying Hub Genes Associated with Hypertrophic Cardiomyopathy by Integrated Bioinformatics Analysis
    Ma, Zetao
    Wang, Xizhi
    Lv, Qingbo
    Gong, Yingchao
    Xia, Minghong
    Zhuang, Lenan
    Lu, Xue
    Yang, Ying
    Zhang, Wenbin
    Fu, Guosheng
    Ye, Yang
    Lai, Dongwu
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2021, 14 : 823 - 837
  • [7] Identification of Novel Genetic Variants and Comorbidities Associated With ICD-10-Based Diagnosis of Hypertrophic Cardiomyopathy Using the UK Biobank Cohort
    Gyftopoulos, Alex
    Chen, Yi-Ju
    Wang, Libin
    Williams, Charles H.
    Chun, Young Wook
    O'Connell, Jeffery R.
    Perry, James A.
    Hong, Charles C.
    FRONTIERS IN GENETICS, 2022, 13
  • [8] Identification of ferroptosis-related genes in heart tissues of patients with hypertrophic cardiomyopathy
    Huang, Fang
    Li, Shujuan
    Zhang, Ailei
    Zhao, Jihuai
    Zhang, Shaoqiang
    Liu, Dongwei
    Chen, Wei
    MEDICINE, 2025, 104 (09) : e41525
  • [9] Restrictive Physiology is Associated With Poor Outcomes in Children With Hypertrophic Cardiomyopathy
    Maskatia, Shiraz A.
    Decker, Jamie A.
    Spinner, Joseph A.
    Kim, Jeffrey J.
    Price, Jack F.
    Jefferies, John L.
    Dreyer, William J.
    Smith, E. O'Brian
    Rossano, Joseph W.
    Denfield, Susan W.
    PEDIATRIC CARDIOLOGY, 2012, 33 (01) : 141 - 149
  • [10] Identification of novel genetic variants associated with feline cardiomyopathy using targeted next-generation sequencing
    Raffle, Jade
    Matos, Jose Novo
    Wallace, Marsha
    Wilkie, Lois
    Piercy, Richard J.
    Elliott, Perry
    Connolly, David J.
    Fuentes, Virginia Luis
    Psifidi, Androniki
    SCIENTIFIC REPORTS, 2025, 15 (01):